Publications by authors named "Nehal Elmansoury"
Article Synopsis
- Pharmacogenomics (PGx) links genetic differences to drug responses, aiming to enhance treatment outcomes and minimize side effects, but it's underutilized in developing countries.
- Surveys conducted in Egypt and Lebanon revealed limited availability of PGx testing in healthcare facilities, with Egypt having some testing and Lebanon offering almost none.
- There is significant interest among pharmacists (over 34%) and physicians (almost 25%) in learning about PGx, with a consensus on the necessity for educational programs to improve PGx implementation in the Middle East.
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a frequent clinical condition globally. Single nucleotide polymorphisms (SNPs) associated with NAFLD have been proposed in the literature and based on bioinformatic screening. The association between NAFLD and genetic variants in Egyptians is still unclear.
View Article and Find Full Text PDF